Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROPINIROLE vs ROSUVASTATIN\ROSUVASTATIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ROPINIROLE vs ROSUVASTATIN\ROSUVASTATIN: Safety Overview

Metric ROPINIROLE ROSUVASTATIN\ROSUVASTATIN
Total FAERS Reports 4,239 557
Deaths Reported 310 13
Death Rate 7.3% 2.3%
Hospitalizations 1,192 170
Average Patient Age 65.5 yrs 65.7 yrs
% Female Patients 56.7% 49.6%
FDA Approval Date Apr 10, 2009 N/A
Manufacturer SOLCO HEALTHCARE US, LLC N/A
Route ORAL N/A
Marketing Status Discontinued N/A